αB-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma

BMC Cancer

Volumn 13, Issue , 2013, Pages

  van de Schootbrugge, Chantal ^a   Bussink, Johan ^b   Span, Paul N ^b   Sweep, Fred C G J ^b   Grénman, Reidar ^c   Stegeman, Hanneke ^b   Pruijn, Ger J M ^a   Kaanders, Johannes H A M ^b   Boelens, Wilbert C ^a,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Carcinoma; Cell movement; CRYAB protein; HspB5; Neoplasm metastasis; Squamous cell of head and neck; Vascular endothelial growth factor A

Indexed keywords

ALPHA CRYSTALLIN; MESSENGER RNA; SMALL INTERFERING RNA; VASCULOTROPIN;

ALPHA CRYSTALLIN GENE; ARTICLE; CANCER CONTROL; CANCER PROGNOSIS; CELL HYPOXIA; CELL MIGRATION; CELL MOTILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; GENE EXPRESSION REGULATION; GENE SILENCING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METASTASIS FREE SURVIVAL; PRIMARY TUMOR; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN SECRETION; RECURRENT CANCER; TUMOR BIOPSY; TUMOR CELL; TUMOR GENE;

ANALYSIS OF VARIANCE; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; COHORT STUDIES; CRYSTALLINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MALE; NEOPLASM PROTEINS; PROGNOSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84875060666     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-128     Document Type: Article

References (40)

1. Chin D, Boyle GM, Williams RM, Ferguson K, Pandeya N, Pedley J, Campbell CM, Theile DR, Parsons PG, Coman WB. αB-crystallin, a new independent marker for poor prognosis in head and neck cancer. Laryngoscope 2005, 115:1239-1242.
2. Boslooper K, King-Yin LA, Gao J, Weinstein S, Johnson N. The clinicopathological roles of αB-crystallin and p53 expression in patients with head and neck squamous cell carcinoma. Pathology 2008, 40:500-504.
3. Moyano JV, Evans JR, Chen F, Lu M, Werner ME, Yehiely F, Diaz LK, Turbin D, Karaca G, Wiley E, Nielsen TO, Perou CM, Cryns VL. αB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest 2006, 116:261-270.
4. Sitterding SM, Wiseman WR, Schiller CL, Luan C, Chen F, Moyano JV, Watkin WG, Wiley EL, Cryns VL, Diaz LK. αB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas. Ann Diagn Pathol 2008, 12:33-40.
5. Kim HS, Lee Y, Lim YA, Kang HJ, Kim LS. αB-Crystallin is a novel oncoprotein associated with poor prognosis in breast cancer. J. Breast Cancer 2011, 14:14-19.
6. Arrigo AP, Simon S, Gibert B, Kretz-Remy C, Nivon M, Czekalla A, Guillet D, Moulin M, Diaz-Latoud C, Vicart P. Hsp27 (HspB1) and αB-crystallin (HspB5) as therapeutic targets. FEBS Lett 2007, 581:3665-3674.
7. Gruvberger-Saal SK, Parsons R. Is the small heat shock protein αB-crystallin an oncogene?. J Clin Invest 2006, 116:30-32.
8. Ghosh JG, Shenoy AK, Clark JI. Interactions between important regulatory proteins and human αB crystallin. Biochemistry 2007, 46:6308-6317.
9. van de Schootbrugge C, Boelens WC. Introduction to Small Heat Shock Proteins. Small Stress Proteins and Human Diseases 2010, 1-27. : Nova Science Publishers. Protein Science and Engineering, Simon S, Arrigo AP.
10. Kase S, He S, Sonoda S, Kitamura M, Spee C, Wawrousek E, Ryan SJ, Kannan R, Hinton DR. αB-crystallin regulation of angiogenesis by modulation of VEGF. Blood 2010, 115:3398-3406.
11. Kerr BA, Byzova TV. αB-crystallin: a novel VEGF chaperone. Blood 2010, 115:3181-3183.
12. Martiny-Baron G, Marme D. VEGF-mediated tumour angiogenesis: a new target for cancer therapy. Curr Opin Biotechnol 1995, 6:675-680.
13. Hu Z, Fan C, Livasy C, He X, Oh DS, Ewend MG, Carey LA, Subramanian S, West R, Ikpatt F, Olopade OI, van de Rijn M, Perou CM. A compact VEGF signature associated with distant metastases and poor outcomes. BMC Med 2009, 7:9.
14. Bremnes RM, Camps C, Sirera R. Angiogenesis in non-small cell lung cancer: the prognostic impact of neoangiogenesis and the cytokines VEGF and bFGF in tumours and blood. Lung Cancer 2006, 51:143-158.
15. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
16. Leemans CR, Braakhuis BJ, Brakenhoff RH. The molecular biology of head and neck cancer. Nat Rev Cancer 2011, 11:9-22.
17. Hoogsteen IJ, Marres HA, Wijffels KI, Rijken PF, Peters JP, van den Hoogen FJ, Oosterwijk E, van der Kogel AJ, Kaanders JH. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin Cancer Res 2005, 11:97-106.
18. Troost EG, Bussink J, Slootweg PJ, Peeters WJ, Merkx MA, van der Kogel AJ, Oyen WJ, Kaanders JH. Histopathologic validation of 3′-deoxy-3′-18F-fluorothymidine PET in squamous cell carcinoma of the oral cavity. J Nucl Med 2010, 51:713-719.
19. van de Klundert FA, Gijsen ML, van den IJssel PR, Snoeckx LH, de Jong WW. αB-crystallin and hsp25 in neonatal cardiac cells--differences in cellular localization under stress conditions. Eur J Cell Biol 1998, 75:38-45.
20. Rijken PF, Bernsen HJ, Peters JP, Hodgkiss RJ, Raleigh JA, van der Kogel AJ. Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys 2000, 48:571-582.
21. Yaromina A, Zips D, Thames HD, Eicheler W, Krause M, Rosner A, Haase M, Petersen C, Raleigh JA, Quennet V, Walenta S, Mueller-Klieser W, Baumann M. Pimonidazole labelling and response to fractionated irradiation of five human squamous cell carcinoma (hSCC) lines in nude mice: the need for a multivariate approach in biomarker studies. Radiother Oncol 2006, 81:122-129.
22. Span PN, Grebenchtchikov N, Geurts-Moespot J, Westphal JR, Lucassen AM, Sweep CG. EORTC Receptor and Biomarker Study Group Report: a sandwich enzyme-linked immunosorbent assay for vascular endothelial growth factor in blood and tumor tissue extracts. Int J Biol Markers 2000, 15:184-191.
23. Zusterzeel PL, Span PN, Dijksterhuis MG, Thomas CM, Sweep FC, Massuger LF. Serum vascular endothelial growth factor: a prognostic factor in cervical cancer. J Cancer Res Clin Oncol 2009, 135:283-290.
24. Geback T, Schulz MM, Koumoutsakos P, Detmar M. TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques 2009, 46:265-274.
25. Goplen D, Bougnaud S, Rajcevic U, Boe SO, Skaftnesmo KO, Voges J, Enger PO, Wang J, Tysnes BB, Laerum OD, Niclou S, Bjerkvig R. αB-crystallin is elevated in highly infiltrative apoptosis-resistant glioblastoma cells. Am J Pathol 2010, 177:1618-1628.
26. Tang Q, Liu YF, Zhu XJ, Li YH, Zhu J, Zhang JP, Feng ZQ, Guan XH. Expression and prognostic significance of the αB-crystallin gene in human hepatocellular carcinoma. Hum Pathol 2009, 40:300-305.
27. Cicek M, Samant RS, Kinter M, Welch DR, Casey G. Identification of metastasis-associated proteins through protein analysis of metastatic MDA-MB-435 and metastasis-suppressed BRMS1 transfected-MDA-MB-435 cells. Clin Exp Metastasis 2004, 21:149-157.
28. Ivanov O, Chen F, Wiley EL, Keswani A, Diaz LK, Memmel HC, Rademaker A, Gradishar WJ, Morrow M, Khan SA, Cryns VL. αB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat 2008, 111:411-417.
29. Geiger TR, Peeper DS. Metastasis mechanisms. Biochim Biophys Acta 2009, 1796:293-308.
30. Hicklin DJ, Ellis LM. Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 2005, 23:1011-1027.
31. Christopoulos A, Ahn SM, Klein JD, Kim S. Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis. Head Neck 2011, 33:1220-1229.
32. Dimberg A, Rylova S, Dieterich LC, Olsson AK, Schiller P, Wikner C, Bohman S, Botling J, Lukinius A, Wawrousek EF, Claesson-Welsh L. αB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Blood 2008, 111:2015-2023.
33. Ruan Q, Han S, Jiang WW, Boulton ME, Chen ZJ, Law BK, Cai J. αB-crystallin, a effecter of unfolded protein response, confers anti-VEGF resistance to breast cancer via maintenance of intracrine VEGF in endothelial cells. Mol Cancer Res 2011, 9:1632-1643.
34. Naresh KN, Nerurkar AY, Borges AM. Angiogenesis is redundant for tumour growth in lymph node metastases. Histopathology 2001, 38:466-470.
35. Kyzas PA, Stefanou D, Batistatou A, Agnantis NJ. Prognostic significance of VEGF immunohistochemical expression and tumor angiogenesis in head and neck squamous cell carcinoma. J Cancer Res Clin Oncol 2005, 131:624-630.
36. Endo K, Shirai A, Furukawa M, Yoshizaki T. Prognostic value of cell motility activation factors in patients with tongue squamous cell carcinoma. Hum Pathol 2006, 37:1111-1116.
37. Ho PY, Chueh SC, Chiou SH, Wang SM, Lin WC, Lee IL, Yang HY, Peng HC, Lai MK. αB-Crystallin in clear cell renal cell carcinoma: Tumor progression and prognostic significance 2012, Oncol: Urol.
38. Benke EM, Ji Y, Patel V, Wang H, Miyazaki H, Yeudall WA. VEGF-C contributes to head and neck squamous cell carcinoma growth and motility. Oral Oncol 2010, 46:e19-e24.
39. Lucas JT, Salimath BP, Slomiany MG, Rosenzweig SA. Regulation of invasive behavior by vascular endothelial growth factor is HEF1-dependent. Oncogene 2010, 29:4449-4459.
40. Singh BN, Rao KS, Ramakrishna T, Rangaraj N, Rao C. Association of αB-crystallin, a small heat shock protein, with actin: role in modulating actin filament dynamics in vivo. J Mol Biol 2007, 366:756-767.